Abiopharma

📋 Norwalk Leslie V (Director) plans to sell 2K shares of GLOBUS MEDICAL INC (at $101.00 each, total $202K) Filed: Jan 08, 2026 | ID: 000004

Securities Fraud Investigation Into agilon health, inc. (AGL) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

New Form SCHEDULE 13D/A - STAAR SURGICAL CO Filed: 2026-01-08 AccNo: 0000921895-26-000058 Size: 66 KB

New Form 1-A POS - Regen BioPharma Inc Filed: 2026-01-08 AccNo: 0001493152-26-000934 Size: 1 MB

Celebrate National Mentoring Month With SWE

New Form S-1 - SCWorx Corp. Filed: 2026-01-08 AccNo: 0001213900-26-002450 Size: 1 MB

Administrative update #SUPPL-1 for BIOCON BIOLOGICS INC. Status: Approval. Decision date: 01/07/2026

(81% Neutral) Salarius Pharmaceuticals, Inc. (SLRX) Announces Business Combination

📋 Tom Penny (Officer) plans to sell 7K shares of Equillium, Inc. (at $1.29 each, total $8K) Filed: Jan 08, 2026 | ID: 000001

New Form SCHEDULE 13G/A - DBV Technologies S.A. Filed: 2026-01-08 AccNo: 0001274173-26-000027 Size: 9 KB

New Form SCHEDULE 13G - Personalis, Inc. Filed: 2026-01-08 AccNo: 0001897612-26-000008 Size: 7 KB

New Form SCHEDULE 13G/A - BIOLIFE SOLUTIONS INC Filed: 2026-01-08 AccNo: 0001897612-26-000006 Size: 7 KB

New Form SCHEDULE 13G - Dyne Therapeutics, Inc. Filed: 2026-01-08 AccNo: 0001897612-26-000009 Size: 7 KB

MiNK Therapeutics and University of Wisconsin–Madison Announce Phase 1 Clinical Trial of Allo-iNKT Cell Therapy (AgenT-797) to Evaluate Prevention of Graft-Versus-Host Disease

New Form SCHEDULE 13G - Ovid Therapeutics Inc. Filed: 2026-01-08 AccNo: 0001623632-26-000052 Size: 45 KB